EPISODE · Jun 13, 2024 · 5 MIN
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
from Rheumnow Podcast · host Dr. Cush
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib
Embed this episode
NOW PLAYING
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
0:00
5:04
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Rheumnow Podcast?
This episode is 5 minutes long.
When was this Rheumnow Podcast episode published?
This episode was published on June 13, 2024.
Can I download this Rheumnow Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!